CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 4 Grant or award EVP, Chief Financial Officer acquired 80,500 shares (grant or award)
- 4 Grant or award President acquired 80,500 shares (grant or award)
- 4 Grant or award SVP, Treasurer & CAO acquired 18,000 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 59,100 shares (grant or award)
- 4 Grant or award EVP, GM Cell Therapy acquired 53,700 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 171,700 shares (grant or award)
- 4 Grant or award EVP, GM Gene Therapy acquired 53,700 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
Page 20 of 65 · 1,296 filings